In particular, anti-TNF-α monoclonal antibodies elicit a highly suppressive effect on ocular inflammatory attacks and have proven to be effective in the treatment of uveitis related to BS by improving visual acuity, showing a good long-term drug retention rate and a steroid-sparing effect [25–28]. This evidence concerns the gene TNF and uveitis.